TipRanks
Spero Therapeutics Inc (DE:2HA)
FRANKFURT:2HA
Germany Market
2HA
Spero Therapeutics
RESEARCH TOOLSreports

Spero Therapeutics (2HA) Income Statement

2 Followers

Spero Therapeutics Income Statement

Last quarter (Q2 2026), Spero Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Spero Therapeutics's net income was $-9.55M. See Spero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 59.62M$ 47.98M$ 103.78M$ 48.58M$ 3.07M
Gross Profit
$ 59.62M$ -48.78M$ 52.34M$ 48.58M$ 3.07M
Operating Expenses
$ 59.64M$ 24.58M$ 30.86M$ 90.78M$ 91.04M
Depreciation and Amortization
$ 0.00$ 2.00K$ 367.00K$ 869.00K$ 646.00K
EBITDA
$ 8.83M$ -72.48M$ 27.15M$ -42.94M$ -87.17M
Operating Income
$ -24.00K$ -73.36M$ 21.48M$ -42.20M$ -87.97M
Other Income/Expenses
$ 8.86M$ 4.79M$ 3.92M$ -4.22M$ -1.78M
Pretax Income
$ 8.83M$ -68.57M$ 25.40M$ -46.41M$ -89.76M
Net Income
$ 8.57M$ -68.57M$ 22.81M$ -46.41M$ -89.76M
Per Share Metrics
Basic EPS
$ 0.15$ -1.27$ 0.43$ -1.23$ -2.91
Diluted EPS
$ 0.15$ -1.27$ 0.43$ -1.23$ -2.91
Weighted Average Shares Outstanding
 56.02M 54.04M 52.70M 37.59M 30.90M
Weighted Average Shares Outstanding (Diluted)
 59.04M 54.04M 52.99M 37.59M 30.90M
Currency in USD

Spero Therapeutics Earnings and Revenue History